06:00Ramona Anna Woitek, Wiener Neustadt / AT, Ferdia Aidan Gallagher, Cambridge / UK
2
Interval cancer rates in the randomised controlled Mammography Screening with Artificial Intelligence trial (MASAI)
--:--Kristina Lang, Malmö / SE
3
Discussant
04:00Fleur Kilburn-Toppin, Cambridge / UK
4
Cancer Detection Rate of breast-MR in supplemental Screening after negative mammography in women with dense breasts - Preliminary results of the MA-DETECT-Study after 350 participants
08:00Sabrina Walter, Mannheim / DE
5
Discussant
04:00Silvia Perez Rodrigo, Madrid / ES
6
Artificial intelligence for cancer detection in population-based mammography screening: Results of a nationwide real-world prospective cohort study (PRAIM)
08:00Stefan Bunk, Berlin / DE
7
Discussant
04:00Elisabetta Giannotti, Cambridge / UK
8
QUANTI CNS Phase 3 Study Results: Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the CNS at Reduced Gadolinium Dose Compared to Standard of Care Macrocyclic GBCAs
08:00Benjamin P Liu, Chicago / US
9
Discussant
04:00Marie-France Bellin, Le Kremlin Bicêtre / FR
10
Small bowel motility quantified by cine MRI to predict longer term response in patients with Crohn’s disease commencing biological therapy: The Motility study
08:00Andrew Plumb, Esher / UK
11
Discussant
04:00Francesca Maccioni, Rome / IT
6 min
Chairpersons' introduction
Ferdia Aidan Gallagher, Cambridge / United Kingdom Ramona Anna Woitek, Wiener Neustadt / Austria
8 min
Interval cancer rates in the randomised controlled Mammography Screening with Artificial Intelligence trial (MASAI)
Kristina Lang, Malmö / Sweden
4 min
Discussant
Fleur Kilburn-Toppin, Cambridge / United Kingdom
8 min
Cancer Detection Rate of breast-MR in supplemental Screening after negative mammography in women with dense breasts - Preliminary results of the MA-DETECT-Study after 350 participants
Sabrina Walter, Mannheim / Germany
4 min
Discussant
Silvia Perez Rodrigo, Madrid / Spain
8 min
Artificial intelligence for cancer detection in population-based mammography screening: Results of a nationwide real-world prospective cohort study (PRAIM)
Stefan Bunk, Berlin / Germany
4 min
Discussant
Elisabetta Giannotti, Cambridge / United Kingdom
8 min
QUANTI CNS Phase 3 Study Results: Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the CNS at Reduced Gadolinium Dose Compared to Standard of Care Macrocyclic GBCAs
Benjamin P Liu, Chicago / United States
4 min
Discussant
Marie-France Bellin, Le Kremlin Bicêtre / France
8 min
Small bowel motility quantified by cine MRI to predict longer term response in patients with Crohn’s disease commencing biological therapy: The Motility study